REFERENCES
- Giani G, Fierbracci P, Bonacci R, et al. Relationship between breast cancer and thyroid disease: Relevance of autoimmune thyroid disorders in breast malignancy. J Clin Endocrinol Metab. 1996; 81: 990–994
- Gogas J, Kouskos E, Tseleni-Balafouta S, Markopoulos C, Ravenas K, Gogas G, Kostakis A. Autoimmune thyroid disease in women with breast carcinoma. Eur J Surg Oncol. 2001; 27: 626–630
- Goldman MB. Thyroid diseases and breast cancer. Epidemiol Rev. 1990; 12: 16–28
- Loeser AA. A new therapy for prevention of post-operative recurrences in genital and breast cancer: A six-year study of prophylactic thyroid treatment. BMJ 1954; 2: 1380–1383
- Macchia E, Concetti R, Burgoni F, et al. Assays of TSH-Receptor antibodies in 576 patients with various thyroid disorders: Their incidence, significance and clinical usefulness. Autoimmunity 1989; 3(2): 103–112
- Martinez L, Castilla JA, Gil T, et al. Thyroid hormones in fibrocystic disease. Eur J Endocrinol. 1995; 132: 673–676
- Mittra I, Hayward JL. Hypothalamic-pituitary-prolactin axis in breast cancer. Lancet 1974; i: 889–891
- Rasmussen B, Feldt Rasmussen U, Hegedus L, Perild H, Bech K, Hoier-Madsen M. Thyroid function in patients with breast cancer. Eur J Cancer Clin Oncol 1987; 23: 553–556
- Smyth PP. Thyroid and breast cancer: A significant association?. Ann Med. 1997; 29: 189–191
- Turken O, Nann Y, Demirbas S, Onde ME, Sayan O, Kandemir EG, Yaylaci M, Ozturk A. Breast Cancer Res. 2003; 5: R110–R113